SiBone
SIBN Healthcare Medical Devices
SiBone’s revenue for fiscal 2025 (year ended December 2025) was $200.9 million, up 20.2% from fiscal 2024. In the quarter to June 2026, revenue grew 15.2%, EPS grew 35.7%, free cash flow grew 60.1% and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow SIBN
SiBone (SIBN) Altman Z-score
SiBone's Altman Z-score for fiscal 2025 is 7.18, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 7.18 | 3.14 |
| FY2024 | 4.04 | (2.37) |
| FY2023 | 6.40 | 4.55 |
| FY2022 | 1.85 | (4.43) |
| FY2021 | 6.28 | (2.77) |
| FY2020 | 9.05 | 4.98 |
| FY2019 | 4.07 | 2.38 |
| FY2018 | 1.69 | — |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.80 | — | 0.96 | |
| Retained earnings / total assets | (1.89) | — | −2.64 | |
| EBIT / total assets | (0.09) | — | −0.31 | |
| Market value of equity / total liabilities | 13.88 | — | 8.33 | |
| Sales / total assets | 0.84 | — | 0.84 | |
| Altman Z-score | Safe zone | 7.18 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Grey zone | 1.52 | ||
Z and Z″ put SiBone in different zones: safe zone by Z, grey zone by Z″.
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| BBNX Beta Bionics, Inc. compare | 16.9× |
| INMD InMode Ltd. compare | 10.4× |
| SIBN SiBone | 7.2× |
| PRCT PROCEPT BioRobotics Corporation compare | 6.4× |
| VREX VAREX IMAGING compare | 1.7× |
| LMRI Lumexa Imaging Holdings, Inc. compare | 1.0× |
| AHCO AdaptHealth Corp. compare | 0.9× |
| IART Integra LifeSciences Holdings Corporation compare | 0.6× |
| QDEL QuidelOrtho Corporation compare | 0.1× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets